Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$28.02 +0.16 (+0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012)

Acadia Pharmaceuticals (ACAD) posted quarterly Debt Ratio of 0.0 for Q1 2012, down 16.75% quarter-over-quarter from 0.0 in Q4 2011.

Analysis

Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012) Analysis & Trends

Acadia Pharmaceuticals' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q1 2012.

  • In Q1 2012, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2012 stood at 0.0 (changed N/A YoY), while the FY2011 annual figure was 0.0, down 50.95% from the prior year.
  • Debt Ratio for Q1 2012 stood at 0.0, down from 0.0 in the prior quarter.
  • The five-year high for Debt Ratio was 0.0 in Q4 2010, with the low at 0.0 in Q1 2012.
  • The 3-year median for Debt Ratio is 0.0 (2011), against an average of 0.0.
  • Peak annual rise in Debt Ratio reached 50.95% in 2011, while the deepest fall reached 50.95% in 2011.
  • Acadia Pharmaceuticals' Debt Ratio stood at 0.0 in 2010, then sank by 50.95% to 0.0 in 2011, then retreated by 16.75% to 0.0 in 2012.
  • Business Quant data shows ACAD's Debt Ratio at 0.0 in Q1 2012, 0.0 in Q4 2011, and 0.0 in Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.05
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.05
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.12
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.47
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.26
10 Acadia Pharmaceuticals 4.82 Bn 3.86 Bn 279.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 0.00
Dec 31, 2011 0.00
Sep 30, 2011 0.00
Jun 30, 2011 0.00
Dec 31, 2010 0.00